文献速递神经肿瘤小儿神经外科与脑积水

儿童中枢神经系统肿瘤的遗传易感性——神经外科医生应了解的内容

Genetic predisposition to central nervous system tumors in children - what the neurosurgeon should know.
PubMed 文献 · Acta Neurochir (Wien) · 2022-06-03

本文为叙述性综述,讨论儿童中枢神经系统(CNS)肿瘤遗传易感性的当前认识、研究方法与术语,并探讨胚系遗传学对神经外科实践的影响。文中指出,至少10%的儿童CNS肿瘤可由已知癌症相关基因的罕见致病性胚系变异解释,且新方法提示更高比例患儿存在潜在遗传病因。理解遗传易感性如何影响肿瘤生物学与临床病程,可能要求调整神经外科治疗。

要点

  • 新一代DNA测序使儿童CNS肿瘤遗传易感性认识显著增加,文献已报告超过2000例患儿的胚系测序结果。
  • 至少10%的儿童CNS肿瘤可由已知癌症相关基因的罕见致病性胚系变异解释,比例因肿瘤类型而异。
  • 新方法持续发现新机制,提示更高比例患儿存在潜在遗传病因;胚系遗传学对神经外科医生日益重要。

核心结论

  • 胚系遗传学对包括神经外科医生在内的临床医生日益重要,本综述提供儿童CNS肿瘤遗传易感性的更新概览,聚焦与小儿神经外科医生相关的方面。

研究设计与样本

  • 叙述性综述,讨论儿童CNS肿瘤遗传易感性的当前认识,概述相关研究方法与术语,并考虑胚系遗传学如何影响神经外科实践。

主要发现

  • 新一代DNA测序通过对大队列进行全外显子/全基因组测序,极大增进了对儿童CNS肿瘤遗传易感性的理解。
  • 迄今科学文献已报告超过2000例CNS肿瘤患儿的胚系测序结果。
  • 至少10%的儿童CNS肿瘤目前可由已知癌症相关基因的罕见致病性胚系变异解释,比例因肿瘤类型而异。
  • 新方法持续揭示新机制,提示更高比例的CNS肿瘤患儿存在潜在遗传病因。
  • 理解遗传易感性如何影响特定患者的肿瘤生物学与临床病程,可能要求调整神经外科治疗。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Historically, few pediatric central nervous system (CNS) tumors were thought to result from genetic predisposition. However, within the last decade, new DNA sequencing methods have led to an increased recognition of high-risk cancer predisposition syndromes in children with CNS tumors. Thus, genetic predisposition is increasingly impacting clinical pediatric neuro-oncology. METHODS: In this narrative review, we discuss the current understanding of genetic predisposition to childhood CNS tumors and provide a general overview of involved research methodologies and terminology. Moreover, we consider how germline genetics may influence neurosurgical practice. RESULTS: Introduction of next-generation DNA sequencing has greatly increased our understanding of genetic predisposition to pediatric CNS tumors by enabling whole-exome/-genome sequencing of large cohorts. To date, the scientific literature has reported germline sequencing findings for more than 2000 children with CNS tumors. Although varying between tumor types, at least 10% of childhood CNS tumors can currently be explained by rare pathogenic germline variants in known cancer-related genes. Novel methodologies continue to uncover new mechanisms, suggesting that a much higher proportion of children with CNS tumors have underlying genetic causes. Understanding how genetic predisposition influences tumor biology and the clinical course in a given patient may mandate adjustments to neurosurgical treatment. CONCLUSION: Germline genetics is becoming increasingly important to clinicians, including neurosurgeons. This review provides an updated overview of genetic predisposition to childhood CNS tumors with focus on aspects relevant to pediatric neurosurgeons.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Foss-Skiftesvik J, Stoltze UK. Genetic predisposition to central nervous system tumors in children - what the neurosurgeon should know. Acta Neurochir (Wien). 2022. PMID: 35660974. doi:10.1007/s00701-022-05258-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。